Dimethylformamide → 4-(1-(3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)piperidin4-yl)butyric acid ethyl ester

HRID 1952830Notes

Reaction equation

HRID 1952830 reaction equation
Br[CH2:2][CH2:3][CH:4]=[C:5]1[C:11]2[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=2[CH2:9][CH2:8][C:7]2[CH:16]=[CH:17][CH:18]=[CH:19][C:6]1=2.[NH:20]1[CH2:25][CH2:24][CH:23]([CH2:26][CH2:27][CH2:28][C:29]([O:31][CH2:32][CH3:33])=[O:30])[CH2:22][CH2:21]1.C(=O)([O-])[O-].[K+].[K+].CN(C)C=O>O.C1C=CC=CC=1>[CH2:32]([O:31][C:29](=[O:30])[CH2:28][CH2:27][CH2:26][CH:23]1[CH2:24][CH2:25][N:20]([CH2:2][CH2:3][CH:4]=[C:5]2[C:11]3[CH:12]=[CH:13][CH:14]=[CH:15][C:10]=3[CH2:9][CH2:8][C:7]3[CH:16]=[CH:17][CH:18]=[CH:19][C:6]2=3)[CH2:21][CH2:22]1)[CH3:33]

Participants

7

Conditions

Temperature
120 °C

Procedure

A mixture of 5-(3-bromopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (5.8 g, 19.8 mmol), ethyl 4-(piperidin-4-yl)butyrate (6.1 g, 29 mmol), potassium carbonate (2.9 g, 21 mmol) and N,N-dimethylformamide (10 ml) was heated at 120° C. for 5 h. After cooling, benzene (50 ml) and water (50 ml) were added and the phases were separated. The organic phase was dried and the solvent was evaporated in vacuo. The residue was purified by column chromatography on silica gel (50 g) using mixtures of benzene and chloroform as eluents to give 6.9 g (83%) of 4-(1-(3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)piperidin4-yl)butyric acid ethyl ester as an oil.

Workup

  1. temperatureAfter cooling
  2. customthe phases were separated
  3. customThe organic phase was dried
  4. customthe solvent was evaporated in vacuo
  5. customThe residue was purified by column chromatography on silica gel (50 g)

Sources & evidence

ORD record
ord-262b123cb6a04b23bb1ec706c0f3d2c2
Source dataset
uspto-grants-2000_09
Patent number
US06114354

Reaction notes

Loading…